about
Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cellsSecondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinomaCorrection: The CD44(high) Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a ExpressionThe CD44(high) tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression.The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancerEctopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer.Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasionp16 Protein and gigaxonin are associated with the ubiquitination of NFκB in cisplatin-induced senescence of cancer cells.IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosisRetroviral gene transfer is inhibited by chondroitin sulfate proteoglycans/glycosaminoglycans in malignant pleural effusions.New gene and cell-based therapies for lung cancer.IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death.Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.A novel role for the coxsackie adenovirus receptor in mediating tumor formation by lung cancer cells.Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity.EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model.Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo.Adenoviral gene transfer is inhibited by soluble factors in malignant pleural effusions.CCL19 reduces tumour burden in a model of advanced lung cancer.Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.Toxin gene-mediated growth inhibition of lung adenocarcinoma in an animal model of pleural malignancy.Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy.Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.Transduction of non-small cell lung cancer cells by adenoviral and retroviral vectors.Cyclooxygenase 2-dependent regulation of antitumor immunity in lung cancer.Identifying obstacles to viral gene therapy for lung cancer. Malignant pleural effusions as a paradigm.Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanism.Molecular conjugate vectors mediate efficient gene transfer into gastrointestinal epithelial cells.Gene transfer mediated by native versus fibroblast growth factor-retargeted adenoviral vectors into lung cancer cells.Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.Receptor-mediated gene delivery employing lectin-binding specificity.Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma.Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses.Soluble coxsackievirus adenovirus receptor is a putative inhibitor of adenoviral gene transfer in the tumor milieu.Intratumoral therapy with cytokine gene-modified dendritic cells in murine lung cancer models.IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer.Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells.Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication
P50
Q24793668-1F786699-CC94-4531-99A1-AD2657E797D3Q28584799-F7A59603-9B3D-49D1-8CF0-61BFC8FF9438Q28676992-71EE6969-FD42-4EF8-A3FC-5F242BED1BE5Q31137385-0303CA9C-7807-4B1D-BA15-004934D81FA0Q33470317-F75FD567-B18A-4C10-8B08-F38DB2415049Q34646939-A1583168-B93A-4388-ADF9-7CACD9A99D9DQ34646962-8C1FD8FD-24D7-4B8C-B66C-7716A0C92F1CQ34683406-A594E20D-2127-444E-987D-B73D9951A70AQ34790518-8E488A16-5B5F-4DCA-AA29-5DB6026E55E3Q35113694-7D121566-0EAF-453D-BD09-4F061EEC93AEQ36223122-97989CC7-0010-423B-AF1C-EC4D22456251Q38322425-5D290295-6957-43AF-BBDF-3BA832971B75Q40278675-D88AB8CE-A511-4506-A5A2-FED4BB06D724Q40514770-39E87319-4C64-4B9E-A07F-864F58E88112Q40564039-E3FD61EE-F7FB-4446-980B-FC32547BB9F3Q40609361-52581815-FC34-47E5-8379-05E27340846EQ41732041-53915E8A-18D6-4A10-8E5D-9FE4255CAE76Q41732556-CEB65264-A41E-42F9-A86C-1EB053EE6E07Q41911701-34E6CE63-D6B5-44C8-9871-7B502CFE7B7EQ42451922-4EA9E798-C5A1-4257-974D-D3E6579ECCFFQ42456569-E087027F-C71D-4C1D-8E1C-BF4B9D0E5BD4Q43279851-0E423667-FE48-4E10-B946-28672F5A19D7Q43449376-D18B66BE-1C93-4DE0-85DC-79AF5468B68CQ43569336-FD66F78E-0BF8-4CFE-BBF0-93B17A3D54ADQ44199029-3662AFBD-913D-4A1F-A1A4-96CE77A99ACDQ44283890-E621FEF7-7AA7-4A33-950A-9C368EB6432DQ44302051-12D9563C-A015-4CA3-A09E-E178BA65C36EQ45092604-6411AFAD-9719-4957-B2B5-E02477FEF9C8Q45207524-4DB576DB-E0AB-49C8-8DD6-D830EAA7509EQ45220555-A1BC5149-9840-406A-84A6-7C8AFF90F2BDQ45867224-16DDE1B4-CF99-4A76-95A0-49AE6C0FECFFQ45876815-E2930310-CE23-4858-B8BA-E139CE8D61E9Q45987105-E6EEDDAE-0A2E-434E-8AC0-DC9FEC5C2385Q46116791-2FC37F15-216A-4DD6-8B00-3566B170294CQ46191346-D0BD8297-8C97-48EE-9F1E-D255355A52B3Q46230783-D72D37EA-38E6-4530-A078-4215D3567B4BQ46356356-CA6C91E3-4AC3-4807-AB03-0A919953A367Q46549031-77B92616-94C3-4167-8479-C0EED6CE3C52Q46928650-B1194398-91AE-49E1-ACEA-6435076E7DD7Q64381013-647230BB-74BA-4C91-8C9C-7656A5ADAC82
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Raj K Batra
@ast
Raj K Batra
@en
Raj K Batra
@es
Raj K Batra
@sl
type
label
Raj K Batra
@ast
Raj K Batra
@en
Raj K Batra
@es
Raj K Batra
@sl
altLabel
Raj K. Batra
@en
prefLabel
Raj K Batra
@ast
Raj K Batra
@en
Raj K Batra
@es
Raj K Batra
@sl
P106
P21
P2798
P31
P496
0000-0002-1126-543X
P569
2000-01-01T00:00:00Z